CLINICAL_TRIALS
trial_result
· 2022-12-29
Clinical Trial Update: Nalbuphine Versus Morphine for Perioperative Tumor Ablation [Phase 4]
Summary
Phase 4 trial update comparing nalbuphine to morphine for perioperative pain management during tumor ablation; current status unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zhongda Hospital | Conditions: Nalbuphine Allergy, Ablation | Phase 4 | Status: UNKNOWN